๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer

โœ Scribed by Christien Gisselbrecht; Frederick P. Smith; John S. MacDonald; Susan J. Korsmeyer; Michel Boiron; Paul V. Woolley; Philip S. Schein

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
289 KB
Volume
51
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase ii study of the combination of e
A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer
โœ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 413 KB ๐Ÿ‘ 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

The combination of cisplatin, doxorubici
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research
โœ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 482 KB ๐Ÿ‘ 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat